Hot Products

Daphnezomine B
Catalog No: CFN98270

Reference standards.

Daphnin
Catalog No: CFN80132

Daphnin can contribute to the allergic potential of chamomile.

Daphnodorin B
Catalog No: CFN92959

Daphnodorin B has antifungal, antimitotic and anti-HIV-1 activity, it induced morphological deformation of P. oryzae mycelia with MMDC values of 73.7 +/- 1.6 microM, it showed moderate activity against microtubule polymerization with IC50 values of 142 +/- 2 microM in vitro, and it moderately active against HIV-1 in vitro. Daphnodorin B shows inhibitory effects of human chymase. Daphnodorin B inhibited tumor growth and metastasis by protecting host immunocyte viability and proliferation potential, and selectively inhibiting tumor cell proliferation.

Daphnoretin
Catalog No: CFN90329

Daphnoretin has strong antiviral activity, mainly on the later phase of the replication cycle. Daphnoretin has anticancer effects on leukemia, osteosarcoma and uterine cervix cancer cells, might through promoting apoptosis in a mitochondria-mediated way; it causes death of HOS cells by blocking cells successively in G2/M phases and activating the caspase-3 pathway.

Daptomycin
Catalog No: CFN60252

D-arabinitol
Catalog No: CFN98779

D-arabinitol is a marker for the diagnosis of disseminated candidiasis and for monitoring response to antifungal therapy.

D-Arabinose
Catalog No: CFN93003

Biosynthesis of D-arabinose in mycobacteria - a novel bacterial pathway with implications for antimycobacterial therapy.

Darutigenol
Catalog No: CFN97006

Darutigenol has obvious antithrombotic effect,its mechanism may be related to inhibition of platelet aggregation and adhesion.

Darutoside
Catalog No: CFN97004

Darutoside can improve skin elasticity, surface appearance and stretch mark removal, through soothing the skin, decreasing inflammation, restoring collagen and promoting collagen production; it could as an appropriate treatment for wounds.

Dasatinib (BMS-354825)
Catalog No: CFN60030

Dasatinib (BMS-354825) is a novel, potent and multi-targeted inhibitor that targets Abl, Src and c-Kit, with IC50 of <1 nM, 0.8 nM and 79 nM in cell-free assays, respectively. Dasatinib induces autophagy and apoptosis with anti-tumor activity.